What is Danaher's life sciences — finite-lived intangible assets, net?

Danaher (DHR) reported life sciences — finite-lived intangible assets, net of $76.00M in Q2 2025.

What does life sciences — finite-lived intangible assets, net mean?

The remaining value of intangible assets like patents and customer lists that are being amortized over time.

Business Segments · Finite-lived intangible assets, net

Life Sciences — Finite-lived intangible assets, net

Analysis

StatementSegment

CategoryCapital Allocation

SignalContext dependent

VolatilityStable

First reportedQ2 2025

Last reportedQ2 2025

Rolls up toIntangible assets — net

How to read this metric

A high balance indicates significant investment in intellectual property, while a declining balance may signal aging assets or a lack of new acquisitions.

Detailed definition

This metric represents the total net book value of intangible assets with a defined useful life, such as patents, custom...

Peer comparison

Standard balance sheet item for companies with significant R&D or acquisition-led growth strategies.

Metric ID: dhr_segment_life_sciences_finite_lived_intangible_assets_net

Historical Data

1 periods

	Q2 '25
Value	$76.00M

Similar Metrics at Other Companies

Morgan StanleyMS View metric

UnitedHealth GroupUNH View metric

AbbVieABBV View metric

Thermo Fisher ScientificTMO View metric

Frequently Asked Questions

What is Danaher's life sciences — finite-lived intangible assets, net?: Danaher (DHR) reported life sciences — finite-lived intangible assets, net of $76.00M in Q2 2025.
What does life sciences — finite-lived intangible assets, net mean?: The remaining value of intangible assets like patents and customer lists that are being amortized over time.